Skip to content

EXOZ EXOZ Preferred Stock, Par or Stated Value Per Share

Preferred Stock, Par or Stated Value Per Share at other companies

Ginkgo Bioworks logo
Ginkgo BioworksDNA
Upexi logo
UpexiUPXI
XCF Global, Inc. Class A Common Stock logo
XCF Global, Inc. Class A Common StockSAFX

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-5.6%
Enterprise value$76.57M+1.0%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's preferred stock, par or stated value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's preferred stock, par or stated value per share?
EXOZ (EXOZ) reported preferred stock, par or stated value per share of $0 in Q1 2026.
How has EXOZ's preferred stock, par or stated value per share changed year-over-year?
EXOZ's preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for EXOZ's preferred stock, par or stated value per share?
Over 2 years (2023 to 2025), EXOZ's preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.